Page 8 - Thomas Jefferson University

Oncology & Cancer

New recommendations on genetic testing for prostate cancer

Prostate cancer is a leading cause of death from cancer in the US and especially in the Philadelphia region. Consistently, Philadelphia has outpaced the state of PA and the nation in diagnoses and death from prostate cancer. ...

Genetics

Gene therapy to reverse heart failure ready for clinical trials

A promising gene therapy developed, in part, at Thomas Jefferson University's Center for Translational Medicine to prevent and reverse congestive heart failure is on the verge of clinical trials, after years of proving itself ...

Oncology & Cancer

Research team identifies a new way to treat prostate cancer

The American Cancer Society estimates there are nearly 300,000 new cases of prostate cancer every year in the U.S., and approximately one in eight men will be diagnosed with prostate cancer in their lifetime. Prostate cancer ...

Neuroscience

Distinctive inflammatory signature found in a genetic form of ALS

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a neurodegenerative disease that strikes nearly 5,000 people in the U.S. every year. About 10% of ALS cases are inherited or familial, often caused ...

page 8 from 40